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ABSTRACT
Characterization of Altered Epithelial Cell Turnover and Differentiation in
Embryonic Murine Lungs That Over-Express Receptors for
Advanced Glycation End-Products (RAGE)
Jeffrey A. Stogsdill
Department of Physiology and Developmental Biology, BYU
Masters of Science
Receptors for advanced glycation end-products (RAGE) are multi-ligand cell
surface receptors highly expressed in the lung that modulate pulmonary inflammation
during disease. However, the contributions of RAGE signaling are unknown during
pulmonary organogenesis. In order to test the hypothesis that RAGE misexpression
adversely affects lung morphogenesis, conditional transgenic mice were generated that
over-express RAGE in alveolar type II cells of the lung. When RAGE is over-expressed
throughout embryogenesis, severe lung hypoplasia ensues, culminating in perinatal
lethality. Flow cytometry and immunohistochemistry employing cell-specific markers
for various distal cell types demonstrated anomalies in key epithelial cell populations
resulting from RAGE up-regulation through embryonic (E) 18.5. Electron microscopy
also identified significant morphological disturbances to distal cell types including
separation from the basement membrane. Possible mechanisms leading to the
disappearance of pulmonary tissue by increased RAGE expression were then evaluated.
A time course of lung organogenesis commencing at E12.5 demonstrated that increased
RAGE expression primarily alters lung morphogenesis beginning at E16.5. TUNEL
immunohistochemistry and immunoblotting for active caspase-3 confirm a shift toward
apoptosis in lungs from RAGE over-expressing mice when compared to wild type
controls. Assaying for NF-κB also revealed elevated nuclear translocation in lungs from
transgenic mice compared to controls. An RT-PCR assessment of genes regulated by
NF-κB demonstrated elevated expression of Fas ligand, suggesting increased activity of
the Fas-mediated signal transduction pathway in which ligand-receptor interaction
triggers cell death. These data provide evidence that RAGE expression must be tightly
regulated during organogenesis. Furthermore, additional elucidation of RAGE
signaling potentially involved in branching morphogenesis and cell cycle abnormalities
may provide insight into the progression of RAGE-mediated lung diseases.
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GENERAL INTRODUCITON
The vertebrate lung is a complex branching organ comprised of numerous
specialized cell types and tissue specific transcription factors (1), necessary to optimize
oxygen intake and release of gaseous byproducts. In total the average human lung
encompasses 70 m2 of surface area, capable of supporting 250 ml/min of oxygen
consumption at rest and upwards of 5500 ml/min oxygen consumption during
strenuous exercise (2). In order to accomplish the efficiency required of the lung,
coordinated and extensive branching events followed by alveolarization take place
during embryogenesis and well into post natal life; the four organogenic periods are
embryonic, pseudoglandular, canalicular and saccular/alveolar (Figure 1). Each of these
stages is identified by differential epithelial and mesenchymal cell expression that
contributes to significant changes in organ structure.

Lung Morphogenesis
The mouse lung “tree” as mapped by Metzger et. al. reveals a remarkably
stereotypical pattern for development (Figure 2) (3). Through the utilization of three
separate modes of branching (domain branching, planar bifurcation and orthogonal
bifurcation), each of which is controlled by a subroutine of local patterning signals
under the direction of large scale signaling, the entirety of the lung is constructed in a
predictable pattern (3).
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The initial stage of lung production begins by the budding of the endoderm as a
ventral diverticulum between the thyroid and the stomach in an area of tissue
expressing thyroid transcription factor-1 (TTF-1) near embryonic day (E) 9-9.5 in the
mouse and at 5 weeks of gestation in the human (1, 2, 4). The primordial lung buds
evaginate into the surrounding splanchnic mesenchyme as primary tubules are formed
(1).

Fibroblast growth factor (Fgf) 10 among other factors is secreted from the

splanchnic mesenchyme and epithelial branch tips in order to direct proper growth and
branching of the newly formed lung buds (5). Upon generation of the rudimentary
lung buds, primary bronchi are differentially separated in the human and mouse to give
rise to left and right lobes. This process induces a trilobed right and bilobed left lung in
humans, and a quadrilobed right and unilobar left lung in the mouse by E12. Although
the lobular outcome between mice and humans differs, the processes which generate
lobe formation are relatively conserved (2).
Formation of the primary airways initiates the pseudoglandular phase of lung
development (E11.5-E16 in the mouse; 5 to 17 weeks in the human) in which extensive
branching and budding occur resembling the appearance of pre-acinar airways which
form the bronchial and bronchiolar tubes. It is at this stage that specialized cell subsets
emerge from undifferentiated tissues and primarily form ciliated, non-ciliated
columnar, goblet and neuroendocrine cells that line the conducting airways, and
alveolar type (AT) I and II cells begin to encompass the respiratory compartments.
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These differentiation events occur in large part via canonical Wnt signaling, among
other pathways, and are induced by peripheral lung mesenchymal cells and
differentiating lung epithelial cells (1, 2, 6-8).
Alveologensis is characterized by dilations in the terminal acinar tubules and it
progresses through the canalicular (murine E16.5 to E17.5 and 16 to 27 weeks of
gestation in the human) and saccular/alveolar (E17.5 through postnatal [PN] 20 in the
mouse, 27 weeks of gestation through two years and beyond in the human) stages of
lung development. Fgf10 signaling events continue throughout the canalicular and
saccular/alveolar periods and control continued airway branching and terminal alveolar
formation (9). NF-ĸB nuclear translocation, either by over-expression or inflammation
induced mechanisms, can disrupt normal late gestational branching morphogenesis by
inhibiting Sp1 mediated Fgf10 expression (10, 11). Extensive mesenchymal thinning
and angiogenesis occur from PN4 until PN20 in order to permit proper gas exchange.
At the core of proper pulmonary organogenesis lies specific signaling pathways
and transcription factor expression, which require precise spatial and temporal
regulation. In addition to those mentioned previously, sonic hedgehog (SHH), bone
morphogenetic protein 4 (BMP4), forkhead box (FOX) proteins and vascular endothelial
growth factors (VEGFs) greatly influence cell activity including proliferation, migration
and differentiation (12-20). Significant alterations in lung formation occur as a result of
pathway and transcription factor misregulation (1).
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The Receptor for Advanced Glycation End-Products
The receptor for advanced glycation end-products (RAGE) is a member of the
immunoglobin superfamily of cell surface receptors.

The receptor contains an

extracellular V-region-like domain crucial for ligand binding and two C-region like
domains, a single-pass hydrophobic transmembrane domain and a short, 43 amino acid,
highly charged cytoplasmic domain essential for intracellular signaling (Figure 3) (21).
The cytoplasmic domain of RAGE contains four possible phosphorylation sites, S391,
S399, S400 and T401, of which only S391 is conserved among humans, mice, Guinea
pigs, rats, rabbits, dogs and cats (22). Replacement of S391 to alanine was sufficient to
abrogate PKCζ-dependent phosphorylation and subsequent signal transduction in vitro
(22). Although not explicitly stated, RAGE acts as a receptor tyrosine kinase (RTK) cell
surface receptor, requiring homodimerization to effectively potentiate intracellular
signaling cascades (23).
RAGE is a dynamic receptor capable of binding a handful of ligands and it has
the ability to distinguish complex tertiary structures (24). Originally characterized and
named for its capacity to bind to non-enzymatically glycoxidized macromolecules,
advanced glycation end-products (AGEs), RAGE can receive other molecules including
pro-inflammatory

cytokine-like

mediators

of

the

S100/calgranulin

family

(S100A8,9,12,14 and S100B), amyloid β-fibrils, high mobility group box 1 (HMGB1),
Mac-1 (21, 25) and specific DNA and RNA tertiary structures (26).
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Because RAGE binds a handful of ligands, it is thus linked to several signaling
pathways. These include PI3/Akt (27), RhoGTPases (28), Jak/STAT (29), and Src family
kinases (30). Of notable interest are two pathways stimulated by RAGE activation that
are in response to either damage-associated molecular patterns (DAMPs) (NF-κB
pathways) (31) or tobacco smoke-induced pulmonary inflammation (Ras pathway) (32).
Key DAMP molecules are those of the S100/calgranulin family and HMGB1, both of
which bind to RAGE among other receptors including toll-like receptor 4 (TLR4) (26,
33). These DAMP molecules, normally secreted post apoptotic or necrotic events, can
serve as trophic factors in low concentrations or enhance the inflammatory/cell death
response in high concentrations as shown by in vitro studies (34).

A handful of

downstream gene products produced through RAGE signaling include NF-κB, Cox-2,
IL-1β, and TNF-α (31). Because the RAGE gene contains NF-κB and SP-1 promoter
binding sites (35) and is regulated by Egr-1 in cases of tobacco smoke-related disease
(36), a possible auto-inflammatory loop may be triggered giving suggestion to RAGE
involvement in chronic disease states.
The RAGE molecule described above, also termed full length-RAGE, is one of
several isoforms that exist for the receptor due to alternative splicing variants of the
RAGE mRNA. Dominant negative RAGE (dn-RAGE) is a membrane anchored splice
variant of RAGE capable of ligand binding but lacking the intracellular domain
necessary for signal transduction. RAGE has also been shown to exist in a soluble
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secreted form esRAGE. The esRAGE isoform yields the same V and C-regions of the
full length-RAGE but lacks both the hydrophobic transmembrane and the intracellular
domains (21). The altered variants of RAGE are thought to bind and mop up ligands
without the consequences of activating signal transduction and initiating gene
transcription and have been proposed as inflammatory reduction targets for various
tissues. Additionally, full-length RAGE can be cleaved by MMPs to render sRAGE, a
non-splice variant of RAGE closely resembling esRAGE in structure and function (37).
RAGE has been found to be expressed in many cell types including endothelium,
smooth muscle, macrophages and epithelium, however it most abundant in the lung
(38) limiting its expression to ATII cells and to the basolateral membranes of ATI
differentiated cells (25). Normally observed in low levels throughout the body and upregulated only in cases of injury and disease, RAGE expression in contrast is found at
high quantities during late lung neonatal development and in adult pulmonary tissue
suggesting possible contributions to homeostasis and organogenesis. Meneghini et al.
(2010) show that ligands including HMGB1 and S100B promote proliferation and
neuronal differentiation of neural progenitor cells upon RAGE binding and subsequent
activation (39). In addition, RAGE has been shown to enhance adherence of epithelial
cells to collagen coated surfaces and dynamically influence cell spreading a possible
role in ATII to ATI cell transition (40). However, there is little evidence demonstrating
the actual roles of RAGE in murine lung development.
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Aside from developmental aspects, RAGE has been linked to numerous
pathological states including diabetes (41), atherosclerosis, sepsis, rheumatoid arthritis
and Alzheimer’s disease (26). Concentrations of RAGE have found to be up-regulated
in the disease states of lung fibrosis (42), acute respiratory distress syndrome (ARDS)
(43), polycystic kidney disease (44) and chronic obstructive pulmonary disease (COPD)
(45) among many others.

Since its identification in response to high AGE

concentrations as in diabetic states, numerous studies have also shown to find a relation
between inflammation and RAGE (24, 46). Specifically the receptor has been found to
up-regulate various cytokines including IL-6 (25), TNF-α (47), IL-1β (48), MCP-1 (49),
IL-8 (49), INF-α (50) and other molecules such as matrix metalloproteinase 9 (MMP-9).
RAGE has also been shown to promote apoptosis through a variety of intrinsic and
extrinsic stress pathways in a host of cell and tissue types (51-53).
In light of these data, RAGE has become increasingly studied within the context
of disease progression, cancer biology and developmental organogenesis. With respect
to lung biology, little is known about the contributions of RAGE to pulmonary
development. RAGE knock-out (KO) mice exist and particularly during the first year of
life, the lungs of these mice are phenotypically indistinguishable from their wild type
counterparts. We therefore sought to test the hypothesis that pulmonary RAGE overexpression would be detrimental to lung biology and development. By obtaining and
mating two transgenic lines of mice (SP-C—rtTA and TetO—RAGE), we generated
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embryos that over-express RAGE in ATII cells of the lung to study the effects of
increased RAGE on branching morphogenesis, pulmonary cellular differentiation and
apoptosis. Our findings have been published in the American Journal of Respiratory
Cell and Molecular Biology.
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Figures

Figure 1
Key morphogenic events in human and mouse lung development. The
primitive endoderm evaginates into the splanchnic mesenchyme to form the initial lung bud
(A). Through reciprocal signaling between the splanchnic mesenchyme and newly formed lung
outgrowth, extensive elongation and branching occur, thereby forming the primary bronchi (BD). Further generational branching and cellular differentiation occur until well-structured
alveoli are present in the distal lung (E). Image regenerated from Warburton et al. 2000 (2).
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Figure 2
Branching morphogenesis of the murine lung.
The stereotypical
branching pattern of the mouse lung is visualized through whole mount staining from E11
through E16 (A-B). The specific branching generations in the bronchi and bronchial tubes are
diagramed up to seven generations (C-D). Image regenerated from Metzger et al. 2008 (3).
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Figure 3
Structure of RAGE. A cartoon image showing full-length, dominantnegative (DN-RAGE) and esRAGE, and highlighting the extracellular (V, C1 and C2),
transmembrane and cytoplasmic domains of RAGE (A). The surface representation model of
RAGE (B). The blue, white and red image shows the charge distribution of amino acids within
the ectodomain of RAGE. Blue areas represent localized positive charge, whereas red areas
represent negatively charged regions. Image regenerated from Fritz, 2011 (54).
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Abstract
Receptors for advanced glycation end-products (RAGE) are cell-surface receptors
expressed by pulmonary tissue that influence alveolar type (AT)II - ATI transition
required for normal alveolar formation. However, the precise contribution of RAGE in
interactions between pulmonary epithelium and splanchnic mesenchyme during lung
organogenesis remains uncertain. In order to test the hypothesis that RAGE
misexpression adversely affects lung morphogenesis, conditional transgenic mice were
generated that over-express RAGE. Mice that over-express RAGE throughout
embryogenesis experienced 100% mortality and significant lung hypoplasia coincident
with large, vacuous areas in the periphery when compared to normal airway and
alveolar architecture observed in control mouse lungs.
Flow cytometry and
immunohistochemistry employing cell-specific markers for distal (FoxA2) and
respiratory epithelium (TTF-1), ATII cells (proSP-C), and ATI cells (T1-α) demonstrated
anomalies in key epithelial cell populations resulting from RAGE up-regulation. These
results reveal that precise regulation of RAGE expression is required during lung
formation. Furthermore, abundant RAGE results in profound alterations in epithelial
cell differentiation that culminate in severe respiratory distress and perinatal lethality.

Key Words: Hypoplasia / Lung / RAGE / Transgenic / Mouse

19

Introduction
Pulmonary development is a highly ordered and coordinated process that
requires precise reciprocal interactions between differentiating respiratory epithelium
derived from endoderm and the surrounding splanchnic mesenchyme. During the
initial embryonic stage of murine lung development, spanning from embryonic (E) day
9.5 to E11.0, primordial lung buds undergo branching to form the main lobar bronchi.
The subsequent pseudoglandular stage (E11.5 to E16.5) is associated with extensive
branching and budding that lead to the formation of the intrapulmonary conducting
and peripheral lung airways.

As embryonic development progresses, distinct

populations of differentiated respiratory epithelial cell types arise, producing a
morphologically dynamic arrangement of cells that line the conducting airways
(ciliated, non-ciliated columnar, goblet and neuroendocrine cells) and respiratory
(alveolar type (AT) I and ATII cells) compartments. During the canalicular (E16.5 to
E17.5) and saccular (E17.5 through postnatal (PN) 4) stages of lung development,
alveolar saccules form via dilations of terminal acinar tubules. In the latter stages of the
saccular period and into the alveolar period (PN5 to PN20), the formation of an
extensive capillary network coincides with mesenchymal thinning necessary for
efficient gas exchange in the neonate (1). It is clear therefore that lung morphogenesis is
dependent upon specific temporal and spatial control of cell proliferation, migration,
and differentiation.
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Numerous signaling and transcriptional control pathways intimately influence
processes that regulate precise deposition of specialized cell types along the proximaldistal pulmonary axis. Such pathways include those associated with fibroblast growth
factors (Fgfs), sonic hedgehog (Shh), bone morphogenetic protein 4 (Bmp4), vascular
endothelial growth factors (Vegfs), thyroid transcription factor 1 (TTF-1), and Wnts (210). When these or other important genetic pathways are misregulated, pulmonary
hypoplasia (incomplete lung development), or pulmonary agenesis (complete lack of
lung formation) may occur resulting in abnormally low or absent bronchopulmonary
segments and terminal alveoli (11).
Receptors for advanced glycation end-products (RAGE) are members of an
immunoglobin superfamily of cell-surface receptors expressed in many cell types
including endothelium, smooth muscle, fibroblasts, and epithelium (12).

RAGE

contains an extracellular ligand-engaging V-region-like domain and two C-region-like
domains, a single transmembrane domain, and a short, highly charged cytoplasmic
domain essential for signal transduction (13-16). RAGE expression is most abundant in
the lung (17,18) and it is prominently detected on membranes of well-differentiated ATI
cells (19). Identification in ATI cells during development (20) has implicated RAGE in
important developmental processes such as the spreading and adherence that
characterize the transitioning of ATII cells into ATI cells necessary for effective gas
exchange and alveolar stability (21). Although first described as a progression factor in

21

cellular responses to hyperglycemia and oxidant stress rich in advanced glycation endproducts (AGEs), RAGE has also been distinguished as a pattern recognition receptor
that binds S100/calgranulins, amyloid-β-peptide, and high mobility group box-1
(HMGB-1) to influence gene expression during disease progression (13,22,23). Despite
up-regulation of the receptor in cases of injury and disease, high levels of temporally
and spatially regulated RAGE expression during lung development and in adult
pulmonary tissue suggest probable functions in lung morphogenesis and homeostasis
(24).

Additionally, RAGE expression in other tissues that coordinate branching

morphogenesis such as the kidney (25) and salivary gland (26) further suggests
functions that are likely associated with organogenesis. Despite these compelling data,
the full extent of RAGE contribution to lung formation and maintenance has not been
adequately evaluated. Understanding the role of RAGE in development, particularly in
the early stages of airway generation and patterning, could provide insights that link
receptor-mediated signal transduction pathways to critical lung-specific transcriptional
control programs of branching morphogenesis and cytodifferentiation.
In the current investigation, we test hypotheses relating to altered RAGE
expression. In a developmental context, RAGE knock out mice exhibit normal lung
morphogenesis and at the conclusion of the alveolar period, are indistinguishable from
wild type mice with basal RAGE expression (27). However with increasing age, lungs
from RAGE knock out mice become increasingly fibrotic (28). While other genes may
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be able to compensate for the absence of RAGE, in the long term, alveolar homeostasis
may be lost by disturbances in alveolar remodeling (29, 30). To date, no research has
been completed that attempts to reconcile potential pulmonary effects when the full
spectrum of RAGE expression (RAGE knock out, wild type, RAGE over-expression) is
evaluated. Utilizing pulmonary epithelial cell-specific transgenic mouse technology, we
demonstrate that RAGE over-expression in respiratory epithelium results in significant
pulmonary hypoplasia and neonatal lethality. This phenotype demonstrates that while
redundant mechanisms may substitute when RAGE is absent, excessive RAGE
availability influences pathways that culminate in dysmorphogenesis. Extending the
research trajectory of this important mouse model may provide profound insight into
precise stages of lung development involving the biology of pulmonary epithelium in
the proximal and distal lung.

Materials and Methods

Mice
All mice were in a C57Bl/6 background including wild type mice (Jackson
Laboratories, Bar Harbor, ME) and RAGE knock out mice (31). Two transgenic lines
were generated and mated to create conditional doxycycline (dox)-inducible mice that
over-express RAGE (Figure 1). Select Dams were fed dox (625 mg/kg; Harlan Teklad,
Madison, WI) from before conception until E18.5 or during various periods where
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indicated.

En block lungs were resected, weighed, and imaged using an Olympus

SZX12 camera or fixed in 4% paraformaldehyde for histological analysis. Tail biopsies
were genotyped by PCR for existence of transgenes using the following primers: SP-CrtTA forward (5’-GAC ACA TAT AAG ACC CTG GTC A-3’) and reverse (5’-AAA ATC
TTG CCA GCT TTC CCC-3’) and TetO-RAGE forward (5’-TGT CGA GTT TAC TCC
CTA TCA GTG-3’) and reverse (5’-GGA GAG AGG ACC TTC CAA GC-3’). PCR
conditions included 95ºC for 2 minutes and 30 cycles at 95ºC for 30 s, 62ºC (SP-C) or
67ºC (RAGE) for 30 s, and 72ºC for 45 s. Mice were housed and utilized in accordance
with protocols approved by the IACUC at Brigham Young University and at least six
mice were included in each group.

Histology and Immunohistochemistry
Lungs from double transgenic and age–matched wild type mice were processed,
embedded in paraffin, and sectioned (32) then stained with hematoxylin and eosin
according to standard procedures.

Antibodies included: proSP-C (1:1000), FoxA2

(1:2000), TTF-1 (1:1000, Seven Hills Bioreagents, Cincinnati, OH), and T1-α (1:2000,
Hybridoma Bank, University of Iowa). Immunohistochemical staining protocols were
discussed previously (32-35).
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RT-PCR and Immunoblotting
Messenger RNA from RAGE knock out, wild type and double transgenic mice
were isolated from lungs using the Absolutely RNA® Kit (Stratagene, La Jolla, CA).
Semi-quantitative RT-PCR analysis of RAGE and GAPDH involved a SuperScript III
Synthesis Kit (Invitrogen) as previously described (24). Lungs were removed from
RAGE knock out, wild type and transgenic mice and total homogenates were quantified
using a BCA Protein Assay kit (Fisher Scientific).

Immunoblotting for RAGE and

GAPDH in equal concentrations of total lung protein was performed as previously cited
(24).

Flow Cytometry
En block embryonic lungs were removed from E18.5 animals and subjected to
flow cytometric analysis using a FACS Canto Flow Cytometer (BD Biosciences, San Jose,
CA, see Online Supplement for experimental details).

Electron Microscopy
Whole

mouse

lungs

were

excised

and

fixed

overnight

in

a

2%

glutaraldehyde/.06M sodium cacodylate solution (pH 7.3), rinsed in sodium cacodylate
and placed in 1% osmium tetroxide/ sodium cacodylate, then uranyl acetate overnight.
Tissues were dehydrated in a graded acetone series and embedded in Spurr’s resin. 80
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nm sections were obtained using a RMC MT-X Ultra Ultramicrotome (Tucson, AZ) and
stained using Reynolds’ lead citrate. Sections were photographed using a FEI Tecnai
T12 electron microscope.

Statistical Analysis
Flow cytometry and lung weights are presented as the means ± S.D. The mean
percentage of ATI and ATII cells in wild type mouse lung was standardized to 1 and
analyzed using the Student’s t test.

Average weights were assessed by one-way

ANOVA and when ANOVA indicated significant differences, the Student’s t test was
used. Values of p ≤ 0.05 were considered significant.

Results

Conditional Over-Expression of RAGE in the Lung
Semi-quantitative RT-PCR and immunoblot analyses were used to evaluate
RAGE mRNA and protein levels so that RAGE induction in transgenic mice could be
verified. RAGE mRNA was undetectable in E18.5 RAGE knock out mouse lungs and
increased expression was observed in lungs from age-matched RAGE transgenic mice
when compared to basal RAGE expression in lungs from non-transgenic control
littermates (Figure 2A). Immunoblotting was performed in order to determine whether
increased RAGE mRNA expression corresponded with augmented protein synthesis.
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RAGE protein expression was significantly increased in E18.5 RAGE transgenic mice
fed dox when compared to dox-administered wild type littermates (Figure 2B).

Increased Pulmonary RAGE Expression Alters Lung Size and Induces Perinatal
Lethality
Gross imaging of lungs from RAGE transgenic mice (Figure 3C) revealed
observable translucency due to tissue loss and weighed significantly less than lungs
from age-matched wild type controls (Figure 3B) or RAGE knock out mice (Figure 3A).
Assessment of pups allowed to deliver at full term revealed that RAGE transgenic mice
fed dox experienced 100% lethality within four hours of birth when compared to 0%
lethality observed among dox-fed single and non-transgenic control littermates.

Over-Expression of RAGE Alters Lung Morphology and Lung-Specific Cell Populations
Hematoxylin and eosin (H&E) staining of lungs from E18.5 RAGE transgenic
mice fed dox revealed extensive morphological disturbances. Large vacuous areas
lined with squamous, cuboidal and columnar cells were pronounced in RAGE
transgenic mice fed dox throughout gestation when compared to dox-exposed control
mouse lungs (Figure 4A and B, asterisks).

Regions of the RAGE transgenic lung

appeared to experience adequate lung parenchymal development potentially capable of
eventual gas exchange (B, arrow); however, significant lung hypoplasia was observed in
the majority of the lung. E18.5 wild type and RAGE transgenic mice that lacked any
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dox administration during embryogenesis were indistinguishable suggesting insertion
of the transgenes alone had no deleterious effects (Figure 4C, D). When transgenic mice
were fed dox during sequential stages of embryogenesis, critical periods of RAGEmediated lung malformation were identified (Figure 4E-H). Dox administration from
E0-8.5 or E8.5-12.5 resulted in no observable differences between RAGE transgenic and
control mouse lung (Figure 4E, F). Dox availability from only E12.5-15.5 (Figure 4G)
resulted in significant lung hypoplasia similar to dox administration from E0-18.5
(Figure 4B, asterisk). An intermediate phenotype characterized by enlarged airways
resulted when dox was administered from E15.5-18.5 (Figure 4H).
Because lungs from RAGE transgenic mice exposed to dox throughout
development experienced significant lung hypoplasia and respiratory failure, potential
abnormalities in specific cell populations were assessed. Expansion or contraction of
cell populations was qualitatively assessed via immunohistochemistry using antibodies
against cell-specific markers. General identification of distal pulmonary epithelium by
FoxA2 and respiratory epithelium by TTF-1 revealed a detectible decrease in epithelial
cell abundance. Specifically, FoxA2 was detected predominantly in terminal airways
and throughout distal tissues in control lungs (Figure 5A) whereas localization was
restricted to a subset of terminal airways and only sporadically detected in distal lung
tissue of RAGE transgenic mice (Figure 5B).

The localization of TTF-1-positive

epithelial cells was similar in both wild type and RAGE transgenic lungs; however, the
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quantity of positive cells was noticeably diminished in lungs in RAGE transgenic mice
(Figure 5D) compared to controls (Figure 5C). Staining for proSP-C, an antibody that
recognizes surfactant protein C in ATII cells prior to secretion revealed undetectable
changes in ATII cell prevalence but increased intensity of proSP-C in individual ATII
cells in RAGE transgenic mouse lungs (Figure 5F, arrow) when compared to controls
(Figure 5E, arrow). Immunostaining for T1-α, an ATI cell-specific marker, revealed
significant decreases in ATI cell populations in RAGE transgenic mouse lungs. Similar
to FoxA2 staining, T1-α localization was limited to the lining of large vacuous areas and
infrequent throughout distal lung tissue of RAGE transgenic mice (Figure 5H), whereas
abundant T1-α expression was detected in terminal airways of lungs from control mice
(Figure 5G).
In order to obtain quantitative data of the alterations in distal lung cell
populations in the lungs from RAGE transgenic mice, flow cytometric analysis was
employed using lungs from dox-fed E18.5 wild type and RAGE transgenic mice. Data
identify a significant decrease in the percentage of ATI and ATII cells in RAGE
transgenic mouse lungs when compared to age-matched wild type lungs (Figure 6A, B).
When the percentage of each cell type from E18.5 wild type lungs was averaged and
normalized to 1, a significantly decreased percentage of both ATI and ATII cells in
RAGE transgenic mouse lungs was discovered (Figure 6C).
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Because general histological staining of RAGE transgenic mice revealed marked
hypoplastic lung formation (Figure 4) and decreased ATI cell abundance (Figure 5),
ultrastructural analysis of the alveolar compartment was undertaken so that the effects
of RAGE over-expression regarding alveolar epithelium and alveolar integrity could be
evaluated.

Electron microscopy revealed discernible, fused basement membranes

contributing to the respiratory membrane in dox-fed wild type mice (Figure 7A,
asterisk) and abnormally arranged and fragmented basement membranes in RAGE
transgenic mice fed dox (Figure 7B, asterisk). Furthermore, ATI cells in wild type mice
appeared to maintain normal attachment to the basement membrane (Figure 7C,
asterisk) whereas remaining ATI cells in RAGE transgenic mice appeared to be in the
process of sloughing off from the lung parenchyma resulting in detectible gaps between
individual cells and lung proper (Figure 7D, asterisk). Interestingly, sloughing ATI cells
appeared to have a bleb-like morphology associated with impaired cell integrity (Figure
7D, arrow) when compared to normal ATI cells in wild type mice (Figure 7C, arrow).

Discussion
A central discovery in the current study is that significant lung hypoplasia and
airspace enlargement develops when RAGE expression is increased in respiratory
epithelium during embryonic development. These compelling data provide intriguing
insight into the role RAGE may have in the orchestration of branching morphogenesis
during lung formation. Because differences in lung development between RAGE knock

30

out and wild type mice are imperceptible, our data suggests that while redundant
receptors likely compensate for the absence of RAGE, increased availability of RAGE at
critical periods of branching morphogenesis permanently impairs normal lung
developmental trajectory by potentially hindering terminal cell type differentiation.
Beginning at approximately E9 and continuing throughout gestation, lung
morphogenesis relies on precise interplay between differentiating foregut endoderm
and surrounding splanchnic mesenchyme. Numerous cell signaling pathways function
during processes of cell differentiation along the proximal-distal pulmonary axis and
misregulation

of

associated

genetic

programs

cause

severe

developmental

abnormalities (6,36-40). For the purposes of considering the effectiveness of the current
RAGE transgenic mouse model, SP-C expression is observed at E10.5, and may even be
discernible as early as E9 (41). Because there still appears to be distal lung epithelial cell
populations in the RAGE transgenic mouse lung exposed to dox throughout gestation,
initial branching of the main stem bronchi and resulting lobe formation may not be
completely perturbed. This determination is reinforced by data showing no difference
between wild type mouse lung and lungs from RAGE transgenic mice fed dox from E08.5 or E8.5-12.5 (Figure 4). Common events in branching morphogenesis and budding
occurring after E12 normally include expansion of both conducting airways and acinar
spaces in the periphery (11), therefore RAGE augmentation appears to limit the
formation and differentiation of secondary and tertiary branching.

These data are
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similar to those involving the deletion of Titf-1, Fgf10, and FgfRIIIb, which each result
in absent lung lobes and a near complete arrest of branching (36,38,42,43). Evidence
that ATI and ATII cells persist in RAGE transgenic mouse lung reveals an intermediate
phenotype; however, and demonstrates that RAGE over-expression throughout
gestation leads to impaired commitment and/or viability of cells necessary in the
derivation of peripheral lung structures.
Because the data reveal abnormal concentrations of ATI and ATII cells in lungs
that over-express RAGE, increased availability of RAGE possibly influences the
regulation of terminal cell differentiation involved in the formation of sufficient ATI
and ATII cells. Such initial dysregulation therefore likely occurs at a point earlier in
lung developmental sequelae than terminal cell differentiation in the respiratory
compartment. Previous research has revealed that RAGE may function in stabilizing
the alveolus by enhancing cell spreading and adherence of alveolar epithelial cells to
collagen-rich surfaces such as those observed in basement membranes (21). Related
work also suggests that RAGE functions in mediating cellular transition from ATII to
ATI cells commonly observed during pulmonary development (21). The roles of RAGE
in ATI cells, which cover more than 95% of the respiratory surface, therefore contributes
to the development of an extremely thin and expansive phenotype, presumably
necessary to ensure effective bi-directional gas exchange. The data presented in the
current investigation show that with only a modest increase in RAGE expression
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(Figure 2) during late stages of lung organogenesis, significant lung hypoplasia results.
The experiments demonstrate that RAGE up-regulation may alter a homeostatic balance
between discrete distal lung cell populations (Figure 6) and instability of the alveolar
compartment as shown by electron microscopy (Figure 7).

In particular, the

ultrastructural analysis depicted in this investigation clearly reveal disrupted basement
membrane and cell integrity suggesting possible increased synthesis and activation of
matrix metalloproteinases (MMPs) and pro-apoptotic molecules (44-46). Because proinflammatory mediators can influence apoptosis of structural cells in the lung and
secretion is considered an upstream event in the pathogenesis of lung hypoplasia and
bronchopulmonary dysplasia (47-50), elucidation of potential RAGE-mediated
imbalances between apoptosis and proliferation in the distal lung is necessary.
The current mouse model induces the expression of full length RAGE capable of
RAGE signaling, therefore RAGE transgenic mice likely distort the ratio between RAGE
and its decoy receptor, soluble RAGE (sRAGE), formed by alternative splicing (51).
Increased availability of RAGE capable of signal transduction therefore pronounces the
effects of RAGE signaling.

Because RAGE signaling sustains inflammation (52),

promotes apoptosis (53), and may stagnate terminal cell proliferation and
differentiation (21,54), persistent RAGE expression may exacerbate developmental
events that contribute to hypoplastic conditions leading to respiratory distress.
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In summary, susceptibility to impaired branching morphogenesis is a feature of
premature lung disease such as bronchopulmonary dysplasia and persistent airspace
enlargement that causes respiratory distress. Our ability to imitate this deleterious
phenotype via the expression of RAGE, a cell surface pattern recognition receptor,
significantly elevates the role of RAGE biology in lung development.

Additional

studies that focus on the role of increased RAGE availability and the mechanisms
leading to pulmonary inflammation, diminished alveolar epithelial cell viability, and
impairment of extracellular matrix/basement membrane durability are underway and
may plausibly lead to the identification of targets for intervention. While the results
presented herein relate to the context of RAGE up-regulation during highly plastic
developmental milestones, increased RAGE expression must also be characterized in
the adult mouse. Ongoing preliminary studies in our lab expand the pathobiological
understanding of increased RAGE expression in the adult. Research reveals that RAGE
transgenic mice administered dox for 30, 60, and 90 days commencing on PN20 (a
period associated with the completion of alveologenesis) results in loss of parenchymal
tissue and enlarged respiratory airspaces.

It is therefore necessary that additional

studies that seek to identify downstream targets of increased RAGE expression and
possible endogenous ligand(s) responsible for orchestrating RAGE-mediated alterations
in lung physiology continue.
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Figures

Figure 1
Doxycycline-inducible expression of RAGE in double transgenic mice.
The rtTA protein was expressed using the human SP-C (hSP-C) promoter in respiratory
epithelium. In the presence of doxycycline (dox), rtTA activates the expression of RAGE by
lung epithelium.
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Figure 2
RAGE transgenic mice have increased pulmonary RAGE expression.
Representative semi-quantitative RT-PCR (A) and immunoblotting (B) revealed undetectable
RAGE expression in RAGE knock out mouse lung and increased expression of RAGE in RAGE
transgenic mice (TG) compared to wild type controls. Densitometry revealed a 60 to 70%
increase in RAGE mRNA expression and approximately 100% increased RAGE protein
expression when band densities from wild type mouse lungs were averaged and normalized to
1. GAPDH was used as a loading control and representative experiments are shown.
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Figure 3
Decreased lung size from RAGE transgenic mice. Representative imaging
of lungs from E18.5 RAGE transgenic mice (C) were smaller and more translucent when
compared to lungs from RAGE knock out (A) and wild type (B) mice. Average lung weights ±
S.D. from at least three mice per group are provided. All images are at 7X magnification and
scale bars represent two mm.
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Figure 4
Lung hypoplasia in RAGE transgenic mice. H&E preparations revealed
significant lung hypoplasia in RAGE transgenic mice exposed to dox from E0 to sacrifice date at
E18.5 (B, asterisks) compared to dox-exposed wild type controls (A). Only sporadic areas of
lung parenchyma in RAGE transgenic mice appeared normal (B, arrow). Wild type (C) and
RAGE TG mice (D) without dox administration appeared normal. Dox administration of RAGE
transgenic mice from E0-8.5 (C), E8.5-12.5 (D), E12.5-15.5 (E), and E15.5-18.5 (F) revealed that
RAGE over-expression from E12.5-15.5 is sufficient to induce significant hypoplasia similar to
dox exposure throughout embryogenesis (asterisk) and that RAGE over-expression from E15.518.5 induces an intermediate phenotype characterized by large conducting airways that extend
into the lung periphery (H). All images are at 100X original magnification and scale bars
represent 500 μm.
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Figure 5
Altered distribution of pulmonary cell types in RAGE transgenic mice.
Immunostaining for epithelium-specific markers FoxA2 (A and B), TTF-1 (C and D), proSP-C (E
and F), and T1-α (G and H) was performed on sections from E18.5 mouse lung exposed to dox
from E0-18.5. FoxA2 intensely identified distal lung epithelium in wild type mouse lung (A)
but was detectibly diminished in RAGE transgenic mice (B). TTF-1 staining was diffusely
identified in peripheral respiratory epithelium in wild type mice (C) and noticeably reduced in
RAGE transgenic mice (D). While the quantity of ATII cells that stain positive for proSP-C were
not perceivably different in RAGE transgenic mice (F) compared to wild type mice (E),
individual ATII cells appeared to have increased proSP-C immunoreactivity (arrows). ATI cell
identification via T1-α staining revealed consistent ATI cell localization throughout the
respiratory compartment in wild type mice (G) compared to significant reductions in ATI cell
quantity in RAGE transgenic mice (H). All images are at 400X original magnification and scale
bars represent 50 μm.
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Figure 6
RAGE transgenic mice have significantly diminished alveolar epithelial
cell quantities. Cell sorting analysis revealed a significant decrease in ATI and ATII cell
populations in whole lungs isolated from RAGE transgenic (B) compared to wild type mice (A).
Phycoerythrin-T1-α antibody complexes (PE-ATI) and fluorescein isothiocyanate-proSP-C
antibody complexes (FITC-ATII) identify populations of ATI and ATII cells, respectively. When
percentages of ATI and ATII cells in dox-exposed control mice were normalized to 1, a
significant decrease in cell quantity was observed in RAGE transgenic mice following dox
administration (C). Images are representative of six mice per group, p = 0.02 and 0.05.
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Figure 7
Ultrastructural analysis of the respiratory membrane in RAGE transgenic
and wild type mice. Electron microscopy revealed structurally sound respiratory membranes in
wild type mice comprising discrete fused basement membranes (A, asterisk) whereas basement
membranes in RAGE transgenic mice (TG) were fragmented and disarranged (B, asterisk). ATI
cells in wild type mice appropriately adhered to the basement membrane (C, asterisk) and
maintained normal cellular morphology (C, arrow); however, ATI cells in RAGE TG mice
appeared to be separating from lung parenchyma (D, asterisk) and had a bleb-like intracellular
appearance associated with cell destabilization was observed (D, arrow). Images are 6,500X (A,
B) or 2,100X (C, D).
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Abstract
Receptors for advanced glycation end-products (RAGE) are multi-ligand cell
surface receptors highly expressed in the lung that contribute to alveolar epithelial cell
differentiation during embryogenesis and the modulation of pulmonary inflammation
during disease. When RAGE is over-expressed throughout embryogenesis, severe lung
hypoplasia ensues, culminating in perinatal lethality. However, possible mechanisms
that lead to the disappearance of pulmonary tissue are unclear. A time course of lung
organogenesis commencing at E12.5 demonstrated that increased RAGE expression
primarily
alters
lung
morphogenesis
beginning
at
E16.5.
TUNEL
immunohistochemistry and immunoblotting for active caspase-3 confirm a shift toward
apoptosis in lungs from RAGE over-expressing mice when compared to wild type
controls. This observation supports previous work wherein electron microscopy
identified cellular blebbing of alveolar epithelium in embryonic RAGE over-expressing
mice. Assaying for NF-κB also revealed elevated nuclear translocation in lungs from
transgenic mice compared to controls. An RT-PCR assessment of genes regulated by
NF-κB demonstrated elevated expression of Fas ligand, suggesting increased activity of
the Fas-mediated signal transduction pathway in which ligand-receptor interaction
triggers cell death. These data provide evidence that RAGE expression must be tightly
regulated during homeostatic organogenesis. Furthermore, additional elucidation of
RAGE signaling potentially involved in cell cycle abnormalities may provide insight
into the progression of RAGE-mediated lung diseases.

Key Words: RAGE, Apoptosis, Lung, Transgenic
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Introduction
The vertebrate lung is a complex branching organ comprised of numerous
specialized cell types programmed by a host of intricate signaling and transcriptional
control mechanisms. During the pseudoglandular stage, undifferentiated cells become
ciliated columnar epithelial cells, non-ciliated Clara cells, goblet cells, and
neuroendocrine cells that line the conducting airways. Distally, parenchymal cells in
the eventual respiratory compartment differentiate to become alveolar type II (ATII)
and I (ATI) cells. Tight regulation of complex interrelated processes that control cell
growth and differentiation is therefore critical in order to form a viable lung (1).
The receptor for advanced glycation end-products (RAGE) is a member of the
immunoglobin superfamily of cell surface receptors. The receptor contains a V-regionlike domain crucial for ligand binding and two C-region like domains, a single-pass
hydrophobic transmembrane domain and a short, 43 amino acid, highly charged
cytoplasmic domain essential for intracellular signaling (2-4).

RAGE is a dynamic

receptor capable of binding ligands with variable, yet related tertiary structures (5).
Initially characterized and named for its ability to bind non-enzymatically glycoxidized
macromolecules, advanced glycation end-products (AGEs), RAGE also binds a myriad
of other molecules including pro-inflammatory cytokine-like mediators of the
S100/calgranulin family, amyloid β-fibrils, and high mobility group box 1 (HMGB-1) (2,
6, 7).
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RAGE is expressed in many cell types including endothelium, smooth muscle,
macrophages and epithelium, however it is most abundantly expressed by alveolar
epithelium (8). While some evidence suggests minimal expression by ATII cells (5, 9),
differentiated ATI cells are the predominant RAGE expressing cells in the lung (10).
RAGE is clearly detected in pulmonary cells during lung neonatal development (11),
suggesting possible contributions to organogenesis and homeostasis. RAGE has been
shown to promote epithelial cell adherence and dynamically influence cell spreading,
implying a possible role in ATII to ATI cell transition (12). Moreover, recent findings
have suggested a role for RAGE in cytoskeletal disruption, revealing possible functions
related to cell plasticity and survivability (13). Expression of RAGE is also up-regulated
in cases of injury and disease.

For example, full-length membrane bound RAGE

(mRAGE) is increased in oxidative asthma (14), smoke related chronic obstructive
pulmonary disease (15-18), acute respiratory distress syndrome (19), and acute lung
injury induced by radon, cytokines, hyperoxia, and lipopolysaccharide (20, 21). Soluble
RAGE (sRAGE) capable of binding ligand but unable to transduce intracellular
signaling is also increased in a subset of these diseased conditions (19, 21-23). However,
precise roles for RAGE during lung development remain enigmatic.
Because RAGE binds specific ligands, it is linked to several downstream
signaling pathways. For example, RAGE activation can occur in response to damageassociated molecular patterns (DAMPs) via the NF-κB pathway (24). Research also
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identifies pro-inflammatory RAGE signaling involving NF-κB following Ras activation
in cells and tissues exposed to tobacco smoke (25). Key DAMP molecules are members
of the S100/calgranulin family and HMGB-1, both of which efficiently bind RAGE (26,
27). These molecules, normally secreted following apoptotic or necrotic events, can
serve as trophic factors in low concentrations or enhance inflammatory/cell death
responses at higher concentrations.

Downstream gene products produced through

RAGE signaling include NF-κB, Cox-2, IL-1β, and TNF-α (28). Because the promoter
for the RAGE gene contains NF-κB binding sites (29) and is regulated by Egr-1 in cases
of tobacco-related disease (30), a possible auto-inflammatory loop may be triggered
suggesting a central role for RAGE in tissue loss observed in chronic disease states.
In the current study, lung developmental progression was evaluated in lungs
that use the promoter for surfactant protein C (SP-C) to conditionally over-express
RAGE in the respiratory compartment. Data reveal that the SP-C promoter is active as
early as E10 in primitive pulmonary epithelial cells in both the proximal and distal lung
(31 and Supplemental Figure 1). However, use of the SP-C promoter to drive RAGE
expression did not induce anomalies until E16.5, which progressively worsened
resulting in severely diminished lung formation at E18.5. Previously published data
revealed that distal lung structures exhibited marked signs of nuclear fragmentation
and cellular blebbing when viewed by electron microscopy (31), both of which are
typical hallmarks of apoptosis. Our work involving immunohistochemical TUNEL
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procedures validate apoptotic characteristics evident in electron microscopy and
revealed

significant

increases

in

cells

that

express

blunt

DNA

fragments.

Immunoblotting of lung lysates also confirmed active apoptosis via a caspase-3
mediated pathway. NF-κB, and a potent pro-inflammatory downstream product, Fas
ligand (FasL), were both up-regulated in the lungs of RAGE TG mice, indicating that
cellular apoptosis was likely activated via extrinsic pathways. Taken together, these
data suggest a homeostatic role for RAGE in normal physiological environments and
provide mechanistic insights into deleterious processes that are activated when RAGE
is over-expressed during development and disease.

Methods and Materials

Mice
Mice were in a C57Bl/6 background (Jackson Laboratories, Bar Harbor, ME).
Two transgenic lines (hSP-C-rtTA and TetO-RAGE) were crossed to create doxycycline
(dox, 625 mg/kg; Harlan Teklad, Madison, WI)-inducible mice that up-regulate RAGE
in alveolar epithelium. RAGE transgenic (TG) mice had both transgenes and controls
were age-matched single or non-transgenic littermates. Dams were fed dox before
conception until sacrifice date at embryonic day (E) 12.5 to E18.5. Tail biopsies were
genotyped as previously described (32).

Mice were utilized in accordance with

protocols approved by the IACUC at Brigham Young University.
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Histology and Immunostaining
Lungs from E15.5-E18.5 RAGE TG and wild type mice (n = 3 per group) were
processed, embedded and sectioned (33). Lungs were stained with hematoxylin and
eosin for general lung morphology at 24 hour intervals beginning at E12.5.
Immunohistochemistry used antibodies for RAGE (AF1145, 1:500, R&D Systems,
Minneapolis, MN) and proliferating cell nuclear antigen (PCNA, SC-7907, 1:500, Santa
Cruz Biotechnology, Santa Cruz, CA). The TdT-FragEL DNA Fragmentation Detection
Kit (Calbiochem, Rockland, MA) was used to immunohistochemically evaluate
apoptosis.

Immunoblotting
Lungs from E15.5-E18.5 RAGE TG mice and wild type controls were
homogenized in RIPA buffer supplemented with protease inhibitors (Thermo Scientific,
Pittsburg, PA). To ensure equal loading of protein samples, quantification of protein
concentration was obtained using the BCA Protein Assay Kit (Thermo Scientific).
Protein samples (10 µg each) were subjected to immunoblotting using anti-PCNA
(1:1000, Santa Cruz), total Caspase-3 (#9662, 1:1000, Cell Signaling, Beverly, MA), RAGE
(AF1145), and GAPDH (11). Membranes were incubated with appropriate secondary
antibodies, detected with ECL-plus (Amersham, Piscataway, NJ) and developed. Band
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densitometry used digitized images and the Un-Scan-It software (Silk Scientific, Orem,
UT).

Assessment of Nuclear NF-κB, FasL and Bcl-2
Nuclear lysates were isolated from lungs from E16.5 RAGE TG and controls (n =
3 per group) using the NE-PER extraction kit (Fisher Scientific). Total nuclear protein
was quantified using the BCA technique (32) and total nuclear NF-κB was assessed in
nuclear lysates (3 µg each) using the ELISA based TransAM p65 NF-κB Transcription
Factor Assay Kit (Active Motif, Carlsbad, CA).

NF-κB activity in lysates from

transgenic mice was reported after normalizing activity in controls to 1. Total RNA
from RAGE TG and wild type lungs (n = 3 per group) was isolated from E16.5 animals
using the Absolutely RNA Kit (Stratagene, Santa Clara, CA). RNA was quantified and
1 µg of each sample was converted to cDNA and assessed using the Mouse NF-κB Regulated cDNA Plate Array (Signosis, Sunnyvale, CA).

Statistical Analysis
For immunohistochemistry, at least eight high-power fields (400X) per slide (n =
3 per group) were randomly imaged and blindly counted PCNA or TUNEL-positive
cells were statistically evaluated at each time point using a Student’s t test of the means.
At least 3 samples were used for immunoblots and cDNA screens per group and a
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Student’s t test was employed to assess the level of significance at α=0.05. All values
were presented as means ± S.D. and values of p ≤ 0.05 were considered significant.

Results

Lung Hypoplasia was Temporally Affected by RAGE Over-Expression During Lung
Organogenesis
Immunostaining for RAGE revealed epithelial-specific patterns of RAGE
augmentation in the RAGE TG mouse compared to wild type controls (Figure 1).
RAGE immunoblotting also confirmed expression in wild type mice as early as E15.5
and significant increases in expression in lung lysates from TG animals (Figure 1I).
Previous work demonstrated that embryonic over-expression of RAGE adversely
affects lung development, leading to an embryonic lethal phenotype. However, the
timing and mechanisms of RAGE-mediated underdevelopment of the lung remained
unclear. A progressive time course evaluation of lungs from RAGE TG and wild type
control mice indicated that elevated RAGE expression adversely impaired lung
morphogenesis beginning at E16.5 (Figure 2I and J), culminating in severely
underdeveloped lungs at E18.5 (Figure 2M and N). Histological evaluation revealed
that lung development transpired normally from E12.5 through E15.5 in RAGE TG mice
(Figure 2B, D, F, and H) when compared to wild type littermates (Figure 2A, C, E, G).
After E15.5, a period that coincides with the canalicular stage of pulmonary
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development, notable tissue loss occurred and the degree of tissue loss increased as
embryogenesis progressed.

Wild type and RAGE TG mice in the absence of dox

administration histologically appeared similar to dox-fed wild type mice (32)
suggesting there were no adverse effects to pulmonary organogenesis due to the
transgenes alone or by dox administration.

Proliferation was Unchanged in the RAGE Over-Expressing Lung
Because diminished cellular proliferation may contribute to lung hypoplasia,
cellular propagation was studied in the context of RAGE over-expression.
Immunohistochemistry of lung samples from E15.5 to E18.5 was performed utilizing
antibodies against proliferating cell nuclear antigen (PCNA), a marker of cell
proliferation that detects cells in the S phase of the cell cycle. As anticipated, numerous
proliferating cells were positively stained for PCNA at each time point in both wild
type and RAGE TG lungs (Figure 3A). After the percentage of PCNA positive cells at
each time point was obtained and evaluated, differences between the groups were not
statistically significant (Figure 3B), even though the sum of all PNCA-positive cells
trended downward as pulmonary development progressed (Supplemental Table).
In order to further assess qualitative PCNA expression (Figure 3A),
immunoblotting for PCNA was performed. Lysates from E15.5-E18.5 lungs resected
from RAGE TG mice revealed diminishing PCNA expression when compared to lungs
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from age-matched controls (Figure 3C and D); however PCNA expression was not
significantly different between the two groups of mice (Figure 3C and D).

Apoptosis was Elevated in the RAGE Over-Expressing Lung
In order to assess whether increased apoptosis contributed to severe lung
hypoplasia observed in RAGE over-expressing mice, a quantitative TUNEL staining
approach was used. The number of positively identified apoptosing cells via TUNEL
staining was significantly increased in lungs from RAGE TG mice compared to wild
type controls at each day from E15.5 through E18.5 (Figure 4A and B). As revealed by
representative immunostains (Figure 4A), cells undergoing apoptosis were sporadically
detected

in

lung

parenchyma.

In

addition

to

the

immunohistochemistry,

immunoblotting for caspase-3 was performed in order to detect both extrinsic and
intrinsic apoptotic pathways. RAGE TG lungs had a significant increase in the amount
of total (35 kDa) and active caspase-3 (17 and 19 kDa forms) compared to wild type
littermates (Figure 4C). Densitometry of the bands showed a significant increase in the
amount of active caspase-3 in RAGE TG mice at E15.5 compared to wild type E15.5
lungs (Figure 4D). While the amount of active caspase-3 in RAGE TG mouse lungs
declined as E18.5 approached, each time point was characterized by significantly
increased active caspase-3 expression when compared to controls (Figure 4D).
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Nuclear Translocation of NF-κB and Expression of its Targets were Misregulated in the
RAGE Over-Expressing Lung
Total nuclear protein was isolated from whole lung lysates procured from E16.5
mice and assessed for NF-κB activity because of the severity of hypoplasia observed at
that time (Figure 2J). After normalizing nuclear NF-κB expression in the wild type
animals to one, ELISA revealed a significant increase in the activation and nuclear
translocation of NF-κB in lungs from RAGE TG mice (Figure 5A). Because NF-κB
activation was elevated in RAGE TG mice, two NF-κB regulated genes that function in
apoptotic pathways were screened. Compared to controls, RAGE TG lungs expressed
Fas ligand (FasL) at levels approximately two-fold higher at E16.5 (Figure 5B).
Significantly increased FasL, known to promote apoptosis following interaction with its
receptor (FasR), suggests that extrinsic apoptotic pathways were activated in RAGE TG
mice.

Interestingly, expression of Bcl-2, an anti-apoptotic factor, was significantly

diminished in RAGE TG mouse lungs at E16.5 (Figure 5C). Additional data further
suggest that abnormal levels of NF-κB, FasL, and Bcl-2 expression in the RAGE TG
mouse after E16.5 continue to adversely affect lung development (not shown).

Discussion
In the current study, we used a gain-of-function methodology to determine
mechanisms that underlie lung hypoplasia resulting from RAGE signaling.

This
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research is a natural extension of our previous work wherein we demonstrated that
RAGE

up-regulation

caused

pulmonary

underdevelopment

via

hindered

cytodifferentiation and possible impairment of branching morphogenesis (32). Through
the utilization of a tetracycline-inducible respiratory epithelial cell-specific RAGE overexpressing mouse, we discovered the precise timing of lung hypoplasia and airspace
enlargement directly attributable to RAGE augmentation in the alveolar compartment
during embryonic development. Furthermore, in spite of possible compensation via
proliferation of respiratory epithelium during the pseudoglandular period of
development, elevated apoptosis of differentiating epithelial cells during the late
pseudoglandular and canalicular periods was a significant cause of irreversible lung
simplification.
Our finding that general lung histology in RAGE TG mice was indistinguishable
compared to age-matched controls through E15.5 (Figure 2) suggested that early
signaling events transpiring between foregut endoderm and surrounding splanchnic
mesoderm were unaffected. In particular, mesenchymal FGF-10 (34), endodermally
derived FGF-R2 (35), SHH/GLI 2,3 (36), and retinoic acid receptors (RARs) (37) each
play important roles during early tracheal-pulmonary morphogenesis. Because lung
organogenesis appeared normal through E15.5, our data reveal that these early
signaling molecules are likely unaffected by RAGE over-expression, despite detection of
RAGE as early as E13.5 (Figure 1).

Despite the lack of an early phenotype, the
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expression of thyroid transcription factor 1 (TTF-1), a critical early lung transcriptional
regulator, is decreased in RAGE TG mice (32). TTF-1 is known to interact with a host of
factors necessary to lung maturation (1), so it is possible that later prenatal events such
as surfactant homeostasis, vasculogenesis, host defense, fluid homeostasis, and
inflammation mediated by TTF-1 contributed to impaired lung formation in the RAGE
TG mouse.
A combination of TUNEL staining and immunoblotting for caspase-3 led to the
discovery that apoptosis was significantly elevated in RAGE TG mice in the late
pseudoglandular (E15.5), canalicular (E16.5-E17.5), and early saccular periods of lung
development (E18.5). In regards to caspase expression, our data supports previous
research that focused on lung apoptosis and the correspondence between elevated total
and active caspase-3 expression (38). The detection of apoptosis during these periods
also corroborated findings by Kresh et al. (39), who studied the ontogeny of apoptosis
in embryonic rat lungs. Specifically, epithelial cell apoptosis was detected from the
canalicular stage and beyond, suggesting the need to precisely control respiratory
epithelial cell deletion during normal lung organogenesis (40). Despite the notion that
deletion of pulmonary epithelium by apoptosis may be a physiologically significant
event in lung remodeling during late stages of gestation, excessive cell death as
observed here (Figure 4) likely contributes to deleterious lung tissue loss.
Clear and predictable patterns of lung and respiratory epithelial cell apoptosis
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during fetal development exist (38, 41). Such patterns provide opportunities for the
elucidation of molecular regulatory pathways that control mechanisms of cell death.
One such well-studied pathway involves the recruitment of activated NF-κB. NF-κB
was initially identified as a transcription factor in B cells and has since been
ubiquitously detected in the cytoplasm of all cell types (42). When stimulated, NF-κB
translocates to the nucleus where it regulates the expression of more than 200 genes that
influence cell growth, survival, and inflammation (43). Because a significant increase in
nuclear NF-κB activity was observed in RAGE TG mice compared to controls (Figure
5A), it appears likely that NF-κB may be an important signaling intermediate
downstream of RAGE. This discovery led to the proposal that the Fas/FasL pathway, a
cascade directly influenced by NF-κB signaling, may be a modulator of late-gestational
apoptosis mediated by RAGE augmentation.

The Fas/FasL pathway is a widely

distributed apoptosis signal transduction pathway in which ligand-receptor interaction
triggers cell death (44, 45). FasL is a type II transmembrane protein belonging to the
tumor necrosis factor family (46, 47) that is cleaved by MMP-7 to elaborate ligand.
Binding of FasL to Fas receptor (FasR) activates intracellular caspases 8 and 3 and
culminates in apoptosis (47, 48). Studies by others show that ATII cells and ATII-like
cell lines express Fas (49) and that apoptosis can be induced in these cells by
crosslinking agonistic anti-Fas antibodies both in vitro and in vivo (50-52).

Our

discovery that FasL was significantly up-regulated in RAGE TG mouse lungs suggests
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that the Fas/FasL pathway may be a pivotal mediator of apoptosis in the airway
epithelial compartment during the pericanalicular period.

Furthermore, because

normal RAGE expression elevates during this pericanalicular period, our data may
suggest remodeling of pulmonary airspaces via ATII apoptosis may occur at least in
part due to RAGE-mediated mechanisms.
An additional observation was that Bcl-2 was down-regulated in the lungs of
RAGE TG mice (Figure 5C). The Bcl-2 gene was originally discovered in a follicular Bcell lymphoma where a chromosomal translocation moves the gene into juxtaposition
with transcriptional enhancer elements of the immunoglobulin heavy chain locus (53).
Bcl-2 is situated upstream of the apoptotic pathway and it provides an important
decisional checkpoint against irreversible cellular damage after delivery of a death
stimulus (54, 55). Specifically, Bcl-2 is an anti-apoptotic mitochondrial outer membrane
permeabilization protein that functions by extending cellular survival via inhibition of a
variety of apoptotic deaths (53-59). We observed that Bcl-2 was decreased in RAGE TG
mouse lungs at E16.5, a period that coincided with apoptosis potentially mediated by
FasL.
In summary, susceptibility to impaired branching morphogenesis and elevated
apoptosis are features of premature lung diseases such as neonatal respiratory distress
and bronchopulmonary dysplasia (BPD).

Because RAGE signaling increases the

secretion of pro-inflammatory cytokines (IL-1β and IL-6) and chemokines (MCP-1)
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known to be involved in BPD pathogenesis (22, 25, 60, 61), the possibility exists that
RAGE, at least in part, contributes to a premature BPD phenotype. Our ability to
imitate and extend postcanalicular apoptosis via up-regulation of FasL, a target of NFκB, through RAGE signaling reveals important RAGE-mediated functions in normal
lung development (Figure 6).

Abnormal RAGE signaling that influences Fas/FasL

pathways should be further studied so that specific contributions to pulmonary
architecture and cellular remodeling in the developing lung can be clarified. While the
current results relate to the context of RAGE up-regulation during developmental
milestones, the apoptotic index stemming from increased RAGE expression in the adult
must also be characterized. It is therefore necessary that additional studies continue,
which seek to identify downstream targets of increased RAGE expression and possible
endogenous ligand(s) responsible for orchestrating RAGE-mediated alterations in lung
formation and physiology.
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Figures

Figure 1
RAGE expression was elevated in embryonic RAGE TG mouse lungs.
Compared to wild type mouse lungs with basal RAGE expression (E and G, arrows),
immunohistochemistry revealed increased RAGE expression in RAGE TG mouse lungs at E13.5
(B), E15.5 (D), E17.5 (F) and E18.5 (H). Original magnification of representative images was
400X. Immunoblotting for RAGE identified detectible expression as early as E15.5 and elevated
expression in lungs from TG mice at from E15.5-E18.5.
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Figure 2
RAGE over-expression altered lung organogenesis beginning at E16.5 and
continuing through E18.5. A representative time course of H&E sections revealed standard
lung formation through E15.5 in the dox-fed RAGE TG mice (B, D, F, H), compared to doxexposed wild type counterparts (A, C, E, G). Histology at E16.5 (J) revealed the initial stages of
aberrant lung structures, culminating in profound tissue loss at E17.5 and E18.5 in the RAGE
TG mouse model (L and N). All images are representative and at 100X original magnification.
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Figure 3
Proliferation was not diminished in RAGE TG lungs. Immunostaining
for PCNA from E15.5 to E18.5 demonstrated wide-spread proliferation in both the wild type
and RAGE TG lungs (A). Cell counts by blinded individuals were performed to view potential
differences in the quantity of proliferating cells. 100 cells were identified and counted in
clusters from at least eight random 400X viewing areas. The percentage of positively stained
(encompassing both punctate and heavy nuclear staining) cells was determined. The
percentage of PCNA-positive cells in RAGE TG lungs was insignificant when compared to the
normalized percentage from wild type lungs (B). Immunoblotting for PCNA from whole lung
lysates suggested no significant change in PCNA expression from E15.5 in the distal lung (D).
A minimum of three animals were evaluated in each experimental group and *p ≤ 0.05.
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Figure 4
Apoptosis was significantly increased in the developing RAGE TG lung.
A detectable increase in the number of actively apoptosing cells by TUNEL staining was
observed in RAGE TG lungs compared to wild type lungs at all time-points tested (A). TUNELpositive cells in 400X images were sporadic throughout the distal lung with occasional staining
found in cuboidal/columnar cells in the airways of RAGE TG mice. Cell counts performed by
blinded individuals demonstrated an increase in the number of positively stained cells at all
time-points (B). Immunoblotting confirmed that active apoptosis was occurring in a caspase-3
mediated manner, indicated by a significant increase in the amount of total and cleaved
caspase-3 products (17 and 19 kDa) found within lung lysates of RAGE TG lungs (C). Density
of the cleaved caspase-3 bands was significantly increased in RAGE TG mouse lungs at all time
points (D). A minimum of three animals were evaluated in each experimental group and *p ≤
0.05.

67

Figure 5
NF-κB and its targets, FasL and Bcl-2, were misregulated in RAGE TG
lungs compared to controls. (A) ELISA experiments showed that active NF-κB protein was
elevated in nuclear lysates from E16.5 RAGE TG mice compared to age-matched wild type
mice. Messenger RNA levels of the pro-apoptotic factor FasL were increased in RAGE TG mice
at E16.5 (B) and anti-apoptotic Bcl-2 mRNA was diminished (C) when compared to controls.
Measurements for FasL and Bcl-2 were standardized to GAPDH. A minimum of three animals
were evaluated in each experimental group and *p ≤ 0.05.
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Figure 6
Working model that demonstrates RAGE-mediated pro-apoptotic
signaling. RAGE signals through Ras and causes the nuclear translocation of active NF-κB. In
the lungs of RAGE TG mice, active caspase-3 and elevated FasL suggest RAGE influences proapoptotic signaling involving these molecules during lung formation.
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Supplemental Figure

Supplemental Figure 1
Lung sections from E13.5-E18.5 RAGE TG mice and wild type
controls were immunostained for proSP-C using a rabbit polyclonal antibody (WRAB-76694,
Seven Hills Bioreagents, Cincinnati, OH) as already described (33).
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Supplemental Table

Table S1: PCNA-positive cells
normalized to WT
Wild type
TG
E15.5
1.0 ± 0.033
0.932 ± 0.097
E16.5
1.0 ± 0.053
1.044 ± 0.027
E17.5
1.0 ± 0.068
1.007 ± 0.062
E18.5
1.0 ± 0.108
1.01 ± 0.090

Supplementary Table 1

Number of PCNA positive lung cells normalized to WT.
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GENERAL DISCUSSION

RAGE Misexpression Yields Hypoplastic Lungs, Anomalous Cytodifferentiation and Abnormal
Branching
RAGE expression has been identified in the murine lung as early as E17.5 by
immunohistochemistry and E16.5 by western blot analysis (1, 2). The work performed
herein represents the data when RAGE is temporally and quantitatively misexpressed
in the distal developing lung. In these studies, increased RAGE expression in ATII cells
led to severely hypoplastic lung at E18.5, a lethal phenotype, when compared to agedmatched littermates. Flow cytometry and immunohistochemistry revealed that distal
cell markers were aberrantly concentrated within the lungs at E18.5, namely pro-SP-C
(ATII cells) and T1-α (ATI cells). The decrease in these two cell populations hints at the
probability that RAGE signaling can affect normal cellular differentiation within the
developing lung. Because ATII and ATI cell markers are initially identified during the
late pseudoglandular phase and into the canalicular phase (3-5), coincident with preRAGE expression in the wild type lung, the data presented here suggest that RAGE
expression could limit terminal differentiation of embryonic epithelial cells into distal
cell types.
Beyond cellular differentiation, other key milestones required for proper lung
formation include branch growth and segmentation of primitive lung buds and branch
tips (4, 6). These events give rise adequate numbers of alveoli and eventual surface area
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for respiration. Fgf10 is one of the key mesenchymal secreted factors necessary for
promoting airway extension and branching (7, 8). Although not explicitly tested here, it
is highly probable that RAGE signaling can alter proper branching morphogenesis in
the lung. Both direct and indirect activation (through cytokine release) of NF-ĸB was
shown to limit Fgf10 expression in the developing lung by binding to the transcriptional
factor Sp1. Due to the inhibition of Fgf10 release from the lung mesenchymal cells, fetal
mouse lung explants failed to properly branch as did wild type lungs (9). Because
RAGE has been shown to promote NF-ĸB nuclear localization, it is likely that the RAGE
over-expressed lungs demonstrate dilated or improperly branched airways. Ultimately,
abnormal RAGE expression underlies the deleterious developmental phenotypes
represented here.

Extrinsic Apoptotic Pathways are Activated Via Increased RAGE Expression
Due to the extreme phenotype witnessed at E18.5, two general possibilities
outlining the pathway of altered lung architecture in the RAGE over-expresser were
identified: early branching failure extending to dilated airways and/or degeneration of
lung tissue following typical pulmonary development. Because of the ties that RAGE
has with apoptosis in other organ and cell systems (10-12) and the “sponge-like”
phenotype observed in driving RAGE expression from E15.5-E18.5 (13), it was
hypothesized that pups exposed to dox throughout embryogenesis would exhibit an
increased apoptosis index coincident with late-stage pulmonary degradation. A time-
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course viewing of lung formation from E12.5 to E18.5 revealed a pattern congruent with
the degeneration model. The data demonstrated here, suggest that RAGE pathways are
tied to increased production of FasL, most likely through NF-ĸB activation, which
stimulate extrinsic apoptotic pathways, culminating in cleavage of caspase-3 and
eventual cell death.
Proliferation markers were also studied to verify any potential imbalances due
RAGE over-expression. Although minimal at best, the RAGE over-expressing lungs
showed no significant change to cellular proliferation from wild type lungs.

This

suggests that a driving force for lung hypoplasticity is due through increased cell death
and not decreased cellular expansion. As hinted previously, it is also highly probable
that branching morphogenic alterations will be witnessed alongside the increased
apoptotic events in these lungs.

Application of the Data and Future Directions
RAGE detection in the murine lung is highly prevalent peri-natally, post-natally
and throughout adulthood (1, 2, 14, 15). However, prior to this study, little was known
about the function of RAGE in the developmental context. The data presented here
strongly suggest that RAGE signaling is associated with apoptosis in a FasL mediated
manner. Previous research has demonstrated that postcanalicular lung development is
characterized by extensive thinning of the interstitium and coordinated loss of ATII
cells (16-18). The loss of ATII cells has been attributed to both terminal differentiation
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into ATI cells and increased ATII cell death through apoptosis (19). Several studies
performed by de Paepe et al, highlight the regulative effects on lung development by
FasL mediated cellular death. Both rabbit and murine models show timely ATII cell
death from E18.5 through PN5. The increase in apoptosis correlated with increased
expression of Fas mRNA and Fas protein to the ATII cells of both model lungs. FasL
also co-localized with ATII cells during the same peri-natal period (20, 21).
Further studies identified the timely kinetics of FasL expression within the distal
lung compartments on ATII behavior. Through an over-expression model, FasL was
shown to function pro-apoptotically in the developmental time period between
canalicular lung development and just before birth.

These mice suffered severe

respiratory distress and eventual death. Strikingly, FasL over-expression both before
and after birth, resulted in increased ATII cell apoptosis, but also expansion of the ATII
population several days post-natally.

Limiting FasL over-expression to post-natal

periods acted in pro-proliferative fashion (22).

These data suggest that that FasL-

mediated cell apoptosis acts as a pruning mechanism to diminish ATII cell populations
before birth (possible to allow space for ATI cells), but reverses its role post-natally to
help re-expand the ATII cell concentration within the lung.
The mechanism by which Fas and FasL are up-regulated post-canalicularly,
however, is still not understood. The work provided in this study regarding pulmonary
RAGE proposes a hypothesis in which homeostatic RAGE signaling promotes timely
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increases in ATII cell Fas and FasL expression in order to finely tune distal lung
development. Because RAGE expression in a wild type lung is present shortly before
the increase in death signals, and because RAGE signaling has been shown to promote
FasL mediated cell death, the proposed hypothesis fits the pruning model described.
Isolation and culturing of primary ATII cells from wild type, RAGE knockout and
RAGE over-expressing lungs should provide opportunities to study the pathways
involved that control FasL release and Fas plasma membrane localization.
The possible control of cell death by RAGE also promotes questions regarding
excessive cell death in pathological or abnormal developmental states where RAGE has
been found to be up-regulated. Bronchopulmonary dysplasia (BPD) is a chronic lung
condition which generally affects preterm babies either through prenatal inflammation
and/or mechanical ventilation. Nearly 12.5% of pregnancies in the United States are
considered preterm, and of that, 43% are affected by BPD (23). BPD is evident by
increased alveolar air space and decreased alveoli number with simultaneous oxidative
stress, sustained inflammation, anti-protease imbalance and increased apoptosis (24,
25).

BPD pathogenesis also involves the increased secretion of pro-inflammatory

cytokines (IL-1β and IL-6) and chemokines (MCP-1) (26-29). The transcription factor
NF-ĸB has also been shown to be a crucial mediator of BPD (23). However the control
mechanisms involved in BPD pathogenesis is still unclear.
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cytokine/chemokine secretion involved in BPD progression including IL-1β, IFN-γ, IL-6,
MCP-1 and other known progression factors including MMP-9 (26-29)(unpublished
data Reynolds). The data proposed here show that RAGE can regulate NF-ĸB activation
within lung morphogenesis and that its over-expressed deleterious effects are
concurrent with “preterm” timing. In addition, targeting of RAGE has been shown to
protect against hyperoxia induced lung injury (30), suggesting that its availability may
promote hyperoxia induced lung injury and promotion of BPD due to mechanical
ventilation for preterm infants. Continued testing using the RAGE transgenic mouse
should shed more light on the possible contributions of RAGE to a BPD phenotype.
Similar mechanisms in place that regulate BPD are also implicated in other
chronic lung diseases including acute respiratory distress syndrome, asthma and
chronic obstructive pulmonary disease (COPD) (31). RAGE has been shown to be
drastically up-regulated in these pathologies (32-34). It is likely that the pathways
implicated in the developmental work performed here are also employed in adulthood
lung diseases.

Work utilizing the RAGE transgenic mouse is already in place

(unpublished data Reynolds), suggesting chronic RAGE up-regulation in ATII cells of
mature lungs can imitate an emphysematous phenotype even in the absence of cigarette
smoke, an exogenous ligand of RAGE (27).
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While the work performed here shows for the first time a mechanism for
pulmonary cell death within the developing lung, further testing is needed to elucidate
the precise mechanisms that control apoptosis of ATII cells upon RAGE up-regulation.
This model may be of considerable use for study of development and adult pathologies
within the lung.
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